淋巴瘤并非“普通瘤” 专家：精准诊断是规范治疗前提

Core Viewpoint - Lymphoma is a malignant tumor that is often misunderstood by the public, with increasing detection rates due to aging populations and improved health awareness [1] Group 1: Disease Overview - Lymphoma encompasses over a hundred types and can occur in various body parts, including lymph nodes, gastrointestinal tract, central nervous system, lungs, breasts, and testicles [1] - Chronic lymphocytic leukemia (CLL) is more common in the elderly, with a median onset age of 60 and above [1] Group 2: Diagnosis and Treatment - Accurate diagnosis is crucial for determining treatment strategies, as different pathological reports can lead to significantly different treatment plans [1] - Current treatment options for lymphoma include chemotherapy, targeted therapy, radiotherapy, immunotherapy, and hematopoietic stem cell transplantation [1] Group 3: Management of Chronic Lymphocytic Leukemia - The emergence of targeted drugs like BTK inhibitors allows for long-term management of CLL as a chronic disease, requiring ongoing medication and regular follow-ups [2] - Elderly patients may face increased risks of adverse drug reactions and interactions due to comorbidities, necessitating careful consideration of treatment options [2] Group 4: Patient Care and Follow-Up - Long-term follow-up is essential for managing CLL, with an emphasis on preventing infections and monitoring immune function [2] - Patients are advised to carefully read discharge summaries that outline follow-up schedules and contact information for healthcare providers to ensure comprehensive management [2]